In conclusion, our study demonstrated that in a cohort of 118 T2DM patients with various degrees of CKD, including ESRD, rs11780592 EPHX2 polymorphism was associated with increased circulating ox-LDL, increased cIMT, and all-cause mortality. The gene discussed is EPHX2; the disease is type 2 diabetes mellitus.